Stefanie Gilles

Stefanie Gilles

Auto-generated profile, based on publicly available information

Stefanie Gilles

Institute of Environmental Medicine and Integrative Health, Faculty of Medicine University Hospital Augsburg Augsburg Germany

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 September 2019 in Allergy
Verified
Journal Article
Closed access
PDF file
SGStefanie Gilles
Stefanie Gilles
CBCornelia Blume
Cornelia Blume
MWMaria Wimmer
Maria Wimmer
Athanasios DamialisAthanasios Damialis
Athanasios Damialis
LMLaura Meulenbroek
Laura Meulenbroek
CTClaudia Traidl-Hoffmann
Claudia Traidl-Hoffmann

12 August 2018 in Experimental Dermatology
Verified
Journal Article
Open access
PDF file
SGStefanie Gilles
Stefanie Gilles
CACezmi Akdis
Cezmi Akdis
RLRoger Lauener
Roger Lauener
PSPeter Schmid‐Grendelmeier
Peter Schmid‐Grendelmeier
TBThomas Bieber
Thomas Bieber
CTClaudia Traidl‐Hoffmann
Claudia Traidl‐Hoffmann
Allergies are usually referred to as type I hypersensitivity reactions against innocuous environmental antigens, characterized by a Th2/IgE‐dominated inflammation. They can manifest themselves in various organs, such as skin, gastrointestinal and respiratory tract, and comprise diseases as diverse as allergic rhinitis and conjunctivitis, bronchial asthma, oral allergy syndrome, food allergy, urticaria and atopic eczema, but also anaphylactic shock. Within the last decades, there was a significant global increase in allergy prevalence, which has been mostly attributed to changes in environment and lifestyle. But which, among all factors discussed, are the most relevant, and what are the mechanisms by which these factors promote or prevent the development of allergic diseases? To answer this, it is necessary to go back to the two key questions that have occupied allergy researchers for the last decades: Firstly, what makes an allergen an allergen? Secondly, why are more and more individuals affected? Within the last decade, we have made considerable progress in answering these questions. This review gives an overview over scientific progress in the field, summarizes latest findings and points out future prospective and research needs.

9 October 2020 in Allergy
Verified
Journal Article
Open access
PDF file
DRDenise Rauer
Denise Rauer
SGStefanie Gilles
Stefanie Gilles
MWMaria Wimmer
Maria Wimmer
UFUlrike Frank
Ulrike Frank
CMConstanze Mueller
Constanze Mueller
FAFrancesca Alessandrini
Francesca Alessandrini
Background: Common ragweed has been spreading as a neophyte in Europe. Elevated CO2 levels, a hallmark of global climate change, have been shown to increase ragweed pollen production, but their effects on pollen allergenicity remain to be elucidated.Methods: Ragweed was grown in climate‐controlled chambers under normal (380 ppm, control) or elevated (700 ppm, based on RCP4.5 scenario) CO2 levels. Aqueous pollen extracts (RWE) from control‐ or CO2‐pollen were administered in vivo in a mouse model for allergic disease (daily for 3‐11 days, n = 5) and employed in human in vitro systems of nasal epithelial cells (HNECs), monocyte‐derived dendritic cells (DCs), and HNEC‐DC co‐cultures. Additionally, adjuvant factors and metabolites in control‐ and CO2‐RWE were investigated using ELISA and untargeted metabolomics.Results: In vivo, CO2‐RWE induced stronger allergic lung inflammation compared to control‐RWE, as indicated by lung inflammatory cell infiltrate and mediators, mucus hypersecretion, and serum total IgE. In vitro, HNECs stimulated with RWE increased indistinctively the production of pro‐inflammatory cytokines (IL‐8, IL‐1β, and IL‐6). In contrast, supernatants from CO2‐RWE‐stimulated HNECs, compared to control‐RWE‐stimulated HNECS, significantly increased TNF and decreased IL‐10 production in DCs. Comparable results were obtained by stimulating DCs directly with RWEs. The metabolome analysis revealed differential expression of secondary plant metabolites in control‐ vs CO2‐RWE. Mixes of these metabolites elicited similar responses in DCs as compared to respective RWEs.Conclusion: Our results indicate that elevated ambient CO2 levels elicit a stronger RWE‐induced allergic response in vivo and in vitro and that RWE increased allergenicity depends on the interplay of multiple metabolites.

4 February 2024 in Allergy
Verified
Journal Article
Closed access
IAIoana Agache
Ioana Agache
CCCarlos Canelo‐Aybar
Carlos Canelo‐Aybar
IAIsabella Annesi-Maesano
Isabella Annesi-Maesano
LCLorenzo Cecchi
Lorenzo Cecchi
DRDavid Rigau
David Rigau
CACezmi A. Akdis
Cezmi A. Akdis

10 April 2023 in Allergy
Verified
Journal Article
Open access
IAIsabella Annesi-Maesano
Isabella Annesi-Maesano
LCLorenzo Cecchi
Lorenzo Cecchi
BBBenedetta Biagioni
Benedetta Biagioni
KCKian Chung
Kian Chung
BCBernard Clot
Bernard Clot
IAIoana Agache
Ioana Agache
Limited number of studies have focused on the impact of pollen exposure on asthma. As a part of the EAACI Guidelines on Environment Science, this first systematic review on the relationship of pollen exposure to asthma exacerbations aimed to bridge this knowledge gap in view of implementing recommendations of prevention. We searched electronic iPubMed, Embase, and Web of Science databases using a set of MeSH terms and related synonyms and identified 73 eligible studies that were included for systemic review. When possible, meta‐analyses were conducted. Overall meta‐analysis suggests that outdoor pollen exposure may have an effect on asthma exacerbation, but caution is needed due to the low number of studies and their heterogeneity. The strongest associations were found between asthma attacks, asthma‐related ED admissions or hospitalizations, and an increase in grass pollen concentration in the previous 2‐day overall in children aged less than 18 years of age. Tree pollen may increase asthma‐related ED visits or admissions lagged up to 7‐day overall in individuals younger than 18 years. Rare data show that among subjects under 18 years of age, an exposure to grass pollen lagged up to 3 days may lower lung function. Further research considering effect modifiers of pollen sensitization, hay fever, asthma, air pollution, green spaces, and pre‐existing medications is urgently warranted to better evaluate the impacts of pollen on asthma exacerbation. Preventive measures in relation to pollen exposure should be integrated in asthma control as pollen increase continues due to climate change.

22 June 2019 in Allergy
Verified
Journal Article
Open access
PDF file
WSWai Tuck Soh
Wai Tuck Soh
LALorenz Aglas
Lorenz Aglas
GMGeoffrey Mueller
Geoffrey Mueller
SGStefanie Gilles
Stefanie Gilles
RWRichard Weiss
Richard Weiss
Fatima FerreiraFatima Ferreira
Fatima Ferreira
Background: Over 100 million people worldwide suffer from birch pollen allergy. Bet v 1 has been identified as the major birch pollen allergen. However, the molecular mechanisms of birch allergic sensitization, including the roles of Bet v 1 and other components of the birch pollen extract, remain incompletely understood. Here, we examined how known birch pollen–derived molecules influence the endolysosomal processing of Bet v 1, thereby shaping its allergenicity.Methods: We analyzed the biochemical and immunological interaction of ligands with Bet v 1. We then investigated the proteolytic processing of Bet v 1 by endosomal extracts in the presence and absence of ligands, followed by a detailed kinetic analysis of Bet v 1 processing by individual endolysosomal proteases as well as the T‐cell epitope presentation in BMDCs.Results: We identified E1 phytoprostanes as novel Bet v 1 ligands. Pollen‐derived ligands enhanced the proteolytic resistance of Bet v 1, affecting degradation kinetics and preferential cleavage sites of the endolysosomal proteases cathepsin S and legumain. E1 phytoprostanes exhibited a dual role by stabilizing Bet v 1 and inhibiting cathepsin protease activity.Conclusion: Bet v 1 can serve as a transporter of pollen‐derived, bioactive compounds. When carried to the endolysosome, such compounds can modulate the proteolytic activity, including its processing by cysteine cathepsins. We unveil a paradigm shift from an allergen‐centered view to a more systemic view that includes the host endolysosomal enzymes.